Format

Send to

Choose Destination
J Thromb Haemost. 2016 Feb;14(2):387-96. doi: 10.1111/jth.13206. Epub 2016 Jan 30.

Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.

Cui XY1,2,3,4, Tinholt M1,3,4,5, Stavik B1,3, Dahm AE2,4,6, Kanse S1,3,7, Jin Y8, Seidl S1,3,7, Sahlberg KK9,10,11, Iversen N5, Skretting G1,3, Sandset PM1,3,4.

Author information

1
Department of Hematology, Oslo University Hospital, Oslo, Norway.
2
Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
3
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
4
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
5
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
6
Department of Hematology, Akershus University Hospital, Lørenskog, Norway.
7
Institute of Basal Medical Sciences, University of Oslo, Oslo, Norway.
8
Department of Biosciences, University of Oslo, Oslo, Norway.
9
Department of Research, Vestre Viken Hospital Trust, Drammen, Norway.
10
K. G. Jebsen Center for Breast Cancer Research, University of Oslo, Oslo, Norway.
11
Oslo Breast Cancer Research Consortium (OSBREAC), Oslo, Norway.

Abstract

ESSENTIALS: A hypoxic microenvironment is a common feature of tumors that may influence activation of coagulation. MCF-7 and SK-BR-3 breast cancer cells and breast cancer tissue samples were used. The results showed transcriptional repression of tissue factor pathway inhibitor expression in hypoxia. Hypoxia-inducible factor 1α may be a target for the therapy of cancer-related coagulation and thrombosis.

BACKGROUND:

Activation of coagulation is a common finding in patients with cancer, and is associated with an increased risk of venous thrombosis. As a hypoxic microenvironment is a common feature of solid tumors, we investigated the role of hypoxia in the regulation of tissue factor (TF) pathway inhibitor (TFPI) expression in breast cancer.

OBJECTIVES:

To explore the transcriptional regulation of TFPI by hypoxia-inducible factor (HIF)-1α in breast cancer cells and their correlation in breast cancer tissues.

METHODS AND RESULTS:

MCF-7 and SK-BR-3 breast cancer cells were cultured in 1% oxygen or treated with cobalt chloride (CoCl2 ) to mimic hypoxia. Time-dependent and dose-dependent downregulation of TFPI mRNA (quantitative RT-PCR) and of free TFPI protein (ELISA) were observed in hypoxia. Western blotting showed parallel increases in the levels of HIF-1α protein and TF. HIF-1α inhibitor abolished or attenuated the hypoxia-induced downregulation of TFPI. Luciferase reporter assay showed that both hypoxia and HIF-1α overexpression caused strong repression of TFPI promoter activity. Subsequent chromatin immunoprecipitation and mutagenesis analysis demonstrated a functional hypoxia response element within the TFPI promoter, located at -1065 to -1060 relative to the transcriptional start point. In breast cancer tissue samples, gene expression analyses showed a positive correlation between the mRNA expression of TFPI and that of HIF-1α.

CONCLUSIONS:

This study demonstrates that HIF-1α is involved in the transcriptional regulation of the TFPI gene, and suggests that a hypoxic microenvironment inside a breast tumor may induce a procoagulant state in breast cancer patients.

KEYWORDS:

HIF-1α protein; blood coagulation; breast cancer; human; hypoxia; tissue factor pathway inhibitor

PMID:
26598923
DOI:
10.1111/jth.13206
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center